Offering healthcare providers a CT system designed for acute and routine
imaging, Toshiba America Medical Systems, Inc. has received FDA
clearance for its AquilionTM RXL Edition CT system. The
Aquilion RXL reconstructs images faster and includes the latest dose
reduction technologies, providing faster, safer information to
physicians and patients.
Aquilion RXL brings the most advanced radiation dose reduction
technology to the 16-detector row CT system with Toshiba's Adaptive
Iterative Dose Reduction 3D (AIDR 3D). AIDR 3D lowers radiation dose
compared with conventional scanning, aiding clinicians in accurate
diagnoses and treatment planning. It is a sophisticated algorithm
designed to work in both the raw data and image data spaces, reducing
noise while attempting to maintain image quality. The system also
features Toshiba's NEMA XR 25 Dose Check Software which improves user
awareness of the radiation dose administered to patients.
Additionally, Aquilion RXL incorporates Toshiba's sophisticated suite of SURETechnologies,
increasing clinical capabilities and significantly improving
"Aquilion RXL is the ideal system for healthcare facilities looking for
a safe, efficient and accurate CT system, combining performance and
value for every-day imaging needs," said Satrajit Misra, senior
director, CT Business Unit, Toshiba. "The integrated AIDR 3D radiation
dose reduction technology creates safer exams for improved patient care."
Toshiba America Medical Systems, Inc.